Abbott Employees Sue Over Higher Costs for Same Health Coverage

2 min readSources: Courthouse News

Abbott employees sued alleging overcharges for identical health insurance plans.

Why it matters: Employers and legal teams must watch healthcare cost disputes closely, as ERISA lawsuits signal growing scrutiny on benefit management and fiduciary duties.

  • On July 14, 2026, Abbott employees filed a class-action suit in Illinois federal court.
  • Plaintiffs claim Abbott offered two health plans with identical coverage but different costs.
  • Employees allege Abbott breached fiduciary duties under ERISA by misleading plan participants.
  • Abbott reported $44.3 billion revenue and is 107th on the Fortune 500 list.

Abbott Laboratories faces a class-action lawsuit filed by a group of its employees on July 14, 2026, in federal court in Illinois. The complaint alleges that Abbott's health insurance plans charged employees differently despite providing identical medical benefits. This lawsuit claims that Abbott offered two options: a Traditional PPO plan, which was more expensive, and another plan with the same coverage but lower costs. Employees who chose the Traditional PPO, according to the complaint, paid substantially more money without receiving any added benefits.

The employees filed the lawsuit under the Employee Retirement Income Security Act (ERISA), focusing on the fiduciary duties of Abbott as a plan sponsor. The complaint states, "Defendant knew, or should have known, that participants who chose the more expensive option (i.e., the Traditional PPO) would virtually always pay more for the same covered medical treatment yet defendant continued to offer that more expensive health insurance option to plan participants for years."

Abbott Laboratories, headquartered in Abbott Park, Illinois, is a significant player in the healthcare industry, generating $44.3 billion in revenue and ranking 107th on the Fortune 500 list. This lawsuit highlights a continuing trend of increasing legal challenges against employers and insurers under ERISA, where employees allege mismanagement of health plans and excessive costs without corresponding benefits.

Similar lawsuits, such as the 2025 class action against UnitedHealthcare for allegedly denying claims using algorithmic practices, indicate heightened scrutiny toward how health insurance plans are administered. This case may prompt corporate legal departments, in-house counsel, and legal operations teams to carefully evaluate their health plan offerings and compliance with fiduciary standards.

By the numbers:

  • $44.3 billion — Abbott Laboratories’ reported revenue
  • 107 — Abbott’s rank on the Fortune 500 list
  • July 14, 2026 — Date Abbott employees filed class-action lawsuit